Literature DB >> 7743367

Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome-where do we stand?

A E Baue.   

Abstract

Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome are problems of medical progress and intensive care units (ICUs) and require prevention of organ failure through excellent patient care. New concepts in prevention include: 1) the need to improve microcirculatory blood flow (Mbf) early after injury or illness, 2) stopping or controlling injury or infection by early definitive operation when necessary, 3) a zero defect operation is necessary, 4) necrotic tissue and an overwhelming inflammatory burden are problems and should be lessened when possible, 5) adequate resuscitation to improve Do2, Vo2, and organ blood flow is necessary, 6) supporting metabolism and the GI tract may decrease complications of injury and sepsis, 7) support of host defense and/or immunomodulation to decrease the incidence of sepsis, and 8) treating the patient and the illness or injury, not just the mediators. Experimental evidence in animals and human volunteers for concepts, mechanisms, and treatment of injury or illness can be substantial and persuasive, but it may be difficult to demonstrate efficacy in sick patients. Clinical situations are variable and complex. It is difficult to dissect out, identify, and control or block a single factor or mediator. All biologic processes require a level of activity that can be hazardous in excess but dangerous if decreased or eliminated. Stimulation of our natural defense or control mechanisms of inflammation, replacement of lost or decreased factors, and better understanding of the interrelationships and mechanisms of inflammation will contribute to therapy. Whether blockade of mediators or treatment of the manifestations of diseases or injuries will have substantial impact remains to be learned. A single magic bullet for complex and diverse illnesses is not likely to appear or to be successful. In this review it was not possible to describe many of the observations and recommendations in this immense and complex field. I apologize to those whose work I have inadvertently not included.

Entities:  

Mesh:

Year:  1994        PMID: 7743367     DOI: 10.1097/00024382-199412000-00001

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

1.  Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock.

Authors:  A S Santibanez-Gallerani; A E Barber; S J Williams; S Davis; Y Zhao; G T Shires
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

2.  Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock.

Authors:  T Sautner; C Wessely; M Riegler; R Sedivy; P Götzinger; U Losert; E Roth; R Jakesz; R Függer
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

3.  Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.

Authors:  A Stehr; F Ploner; I Tugtekin; M Matejovic; M Theisen; C Zülke; M Georgieff; P Radermacher; K-W Jauch
Journal:  Intensive Care Med       Date:  2003-05-09       Impact factor: 17.440

4.  Hepatic microcirculation in murine sepsis: role of lymphocytes.

Authors:  Georg Singer; Karen Y Stokes; D Neil Granger
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

5.  Transcriptional Regulation of the Group IIA Secretory Phospholipase A2 Gene by C/EBPδ in Rat liver and its Relationship to Hepatic Gluconeogenesis during Sepsis.

Authors:  Rei-Cheng Yang; Chin Hsu; Tzu-Ying Lee; Kung-Kai Kuo; Shou-Mei Wu; Yen-Hsu Chen; Mei-Ling Ho; Xing-Hai Yao; Chia-Hsiung Liu; Maw-Shung Liu
Journal:  Emerg Med (Los Angel)       Date:  2013-08-28

6.  Role of lung contusions on posttraumatic inflammatory response and organ dysfunction in traumatized patients.

Authors:  Marcus Maier; Emanuel V Geiger; Sebastian Wutzler; Mark Lehnert; Andreas Wiercinski; Wim A Buurman; Ingo Marzi
Journal:  Eur J Trauma Emerg Surg       Date:  2009-09-17       Impact factor: 3.693

7.  Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model.

Authors:  Mohamed Hamed Hussein; Ghada A Daoud; Hiroki Kakita; Shin Kato; Tatenobu Goto; Michi Kamei; Kenji Goto; Yasuhiko Ozaki; Tetsuya Ito; Sumio Fukuda; Ineko Kato; Satoshi Suzuki; Takashi Hashimoto; Hajime Togari
Journal:  Pediatr Surg Int       Date:  2009-10-03       Impact factor: 1.827

8.  Fish oil improves hemodynamic stabilization and inflammation after resuscitation in a rat model of hemorrhagic shock.

Authors:  Yang Li; Xinying Wang; Ning Li; Jieshou Li
Journal:  Lipids Health Dis       Date:  2012-01-10       Impact factor: 3.876

9.  Resolution and outcome of acute circulatory failure does not correlate with hemodynamics.

Authors:  Matti Suistomaa; Ari Uusaro; Ilkka Parviainen; Esko Ruokonen
Journal:  Crit Care       Date:  2003-06-16       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.